-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $8

Benzinga·08/06/2026 17:02:49
Listen to the news
RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $15 to $8.